PPARGC1A and metabolic dysfunction-associated steatotic liver disease: Luteolin prevents NAFLD by enhancing mitochondrial function, increasing succinate dehydrogenase activity, and upregulating the AMPK/PGC-1α pathway to promote mitochondrial biogenesis.